Patients with OSA have decreased omentin levels, which are associated with sleep parameters, including AHI, SpO2, percentage of REM sleep, hsCRP, HDL, and adiponectin levels. This evidence concerns the gene ITLN1 and obstructive sleep apnea syndrome.